PDS-1.0
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for PDS-1.0, covering 2012-08-22 to 2015-03-05. Get the full timeline:
Most recent: Clinical Trial Update: Preliminary Safety and Efficacy of the PDS-1.0 in Patients With Neovascular Age Related Macular Degeneration (AMD) [Phase 1]